PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival
Cell Reports, ISSN: 2211-1247, Vol: 18, Issue: 4, Page: 918-932
2017
- 152Citations
- 151Captures
- 6Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations152
- Citation Indexes152
- 152
- CrossRef36
- Captures151
- Readers151
- 151
- Mentions6
- News Mentions4
- News4
- Blog Mentions1
- Blog1
- References1
- Wikipedia1
Most Recent Blog
Targeting Parkinson’s-linked protein could neutralize 2 of the disease’s causes
Researchers report they have discovered how two problem proteins known to cause Parkinson’s disease are chemically linked, suggesting that someday, both could be neutralized by a single drug designed to target the link. A report on their discovery appears in the Jan. 24 issue of Cell Reports. The investigators’ new experiments build on evidence reported [...]
Most Recent News
Key Proteins Associated With Parkinson's Disease Symptoms Identified
Highlights Two keys proteins that are associated with Parkinson's disease were identified by a research team from the Johns Hopkins University. These proteins are chemically
Article Description
Mutations in PTEN-induced putative kinase 1 ( PINK1 ) and parkin cause autosomal-recessive Parkinson’s disease through a common pathway involving mitochondrial quality control. Parkin inactivation leads to accumulation of the parkin interacting substrate (PARIS, ZNF746) that plays an important role in dopamine cell loss through repression of proliferator-activated receptor gamma coactivator-1-alpha (PGC-1α) promoter activity. Here, we show that PARIS links PINK1 and parkin in a common pathway that regulates dopaminergic neuron survival. PINK1 interacts with and phosphorylates serines 322 and 613 of PARIS to control its ubiquitination and clearance by parkin. PINK1 phosphorylation of PARIS alleviates PARIS toxicity, as well as repression of PGC-1α promoter activity. Conditional knockdown of PINK1 in adult mouse brains leads to a progressive loss of dopaminergic neurons in the substantia nigra that is dependent on PARIS. Altogether, these results uncover a function of PINK1 to direct parkin-PARIS-regulated PGC-1α expression and dopaminergic neuronal survival.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2211124716318125; http://dx.doi.org/10.1016/j.celrep.2016.12.090; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85010461607&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/28122242; https://linkinghub.elsevier.com/retrieve/pii/S2211124716318125; https://dx.doi.org/10.1016/j.celrep.2016.12.090; https://secure.jbs.elsevierhealth.com/action/getSharedSiteSession?rc=2&redirect=http%3A%2F%2Fwww.cell.com%2Fcell-reports%2Fabstract%2FS2211-1247%252816%252931812-5%3F_returnURL%3Dhttp%253A%252F%252Flinkinghub.elsevier.com%252Fretrieve%252Fpii%252FS2211124716318125%253Fshowall%253Dtrue&code=cell-site; http://www.cell.com/cell-reports/fulltext/S2211-1247(16)31812-5?sf52566363=1; http://www.cell.com/article/S2211124716318125/abstract; http://www.cell.com/article/S2211124716318125/fulltext; http://www.cell.com/article/S2211124716318125/pdf; https://www.cell.com/cell-reports/abstract/S2211-1247(16)31812-5; http://linkinghub.elsevier.com/retrieve/pii/S2211124716318125
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know